Since in vitro studies have shown that the IL-8 expression in ovarian cancer cells is regulated by p38 and ERK1/2 kinases [45–47], it seems plausible that Bay 117085, as a single agent, increases the IL-8 expression in mice by activating p38 and/or ERK1/2. This evidence concerns the gene MAPK3 and ovarian cancer.